Introduction

This page provides a comprehensive analysis of the known insider trading history of Tapper Amy E.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Tapper Amy E. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:IMGO / Imago BioSciences Inc Chief, Technical Operations 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Tapper Amy E.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Tapper Amy E. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2023-01-11 2023-01-11 4 IMGO Imago BioSciences, Inc.
Common Stock
U - Other -141,094 0 -100.00 36.00 -5,079,384
2023-01-05 2023-01-03 4 IMGO Imago BioSciences, Inc.
Common Stock
M - Exercise 1,379 141,094 0.99 22.76 31,386 3,211,299
2023-01-05 2023-01-03 4 IMGO Imago BioSciences, Inc.
Common Stock
M - Exercise 12,400 139,715 9.74 4.20 52,080 586,803
2023-01-05 2023-01-03 4 IMGO Imago BioSciences, Inc.
Common Stock
M - Exercise 7,482 127,315 6.24 2.52 18,855 320,834
2022-12-20 2022-12-16 4 IMGO Imago BioSciences, Inc.
Common Stock
S - Sale -100,302 119,047 -45.73 35.78 -3,588,725 4,259,406
2022-12-20 2022-12-16 4 IMGO Imago BioSciences, Inc.
Common Stock
M - Exercise 18,009 219,349 8.94 1.52 27,374 333,410
2022-12-20 2022-12-16 4 IMGO Imago BioSciences, Inc.
Common Stock
M - Exercise 44,500 201,340 28.37 2.52 112,140 507,377
2022-12-20 2022-12-16 4 IMGO Imago BioSciences, Inc.
Common Stock
M - Exercise 2,380 156,840 1.54 2.27 5,403 356,027
2022-12-20 2022-12-16 4 IMGO Imago BioSciences, Inc.
Common Stock
M - Exercise 5,952 154,460 4.01 2.19 13,035 338,267
2022-12-20 2022-12-16 4 IMGO Imago BioSciences, Inc.
Common Stock
M - Exercise 29,461 148,508 24.75 2.10 61,868 311,867
2022-11-04 2022-11-02 4 IMGO Imago BioSciences, Inc.
Common Stock
S - Sale X -750 119,047 -0.63 17.90 -13,425 2,130,941
2022-11-04 2022-11-02 4 IMGO Imago BioSciences, Inc.
Common Stock
M - Exercise X 750 119,797 0.63 2.52 1,890 301,888
2022-08-16 2022-08-15 4 IMGO Imago BioSciences, Inc.
Common Stock
S - Sale X -11,500 119,047 -8.81 19.26 -221,545 2,293,417
2022-08-16 2022-08-15 4 IMGO Imago BioSciences, Inc.
Common Stock
M - Exercise X 11,500 130,547 9.66 2.52 28,980 328,978
2022-08-16 2022-08-12 4 IMGO Imago BioSciences, Inc.
Common Stock
S - Sale X -750 119,047 -0.63 17.90 -13,425 2,130,941
2022-08-16 2022-08-12 4 IMGO Imago BioSciences, Inc.
Common Stock
M - Exercise X 750 119,797 0.63 2.52 1,890 301,888
2022-07-21 2022-07-20 4 IMGO Imago BioSciences, Inc.
Common Stock
S - Sale X -750 119,047 -0.63 17.90 -13,425 2,130,941
2022-07-21 2022-07-20 4 IMGO Imago BioSciences, Inc.
Common Stock
M - Exercise X 750 119,797 0.63 2.52 1,890 301,888
2022-02-15 2022-02-11 4 IMGO Imago BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise X -3,000 20,738 -12.64
2022-02-15 2022-02-11 4 IMGO Imago BioSciences, Inc.
Common Stock
S - Sale X -3,000 119,047 -2.46 23.78 -71,347 2,831,211
2022-02-15 2022-02-11 4 IMGO Imago BioSciences, Inc.
Common Stock
M - Exercise X 3,000 122,047 2.52 1.52 4,560 185,511
2022-02-11 2022-02-09 4 IMGO Imago BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise X -3,000 23,738 -11.22
2022-02-11 2022-02-09 4 IMGO Imago BioSciences, Inc.
Common Stock
S - Sale X -3,000 119,047 -2.46 21.54 -64,614 2,564,022
2022-02-11 2022-02-09 4 IMGO Imago BioSciences, Inc.
Common Stock
M - Exercise X 3,000 122,047 2.52 1.52 4,560 185,511
2022-02-03 2022-02-01 4 IMGO Imago BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,500 53,023 -10.92
2022-02-03 2022-02-01 4 IMGO Imago BioSciences, Inc.
Common Stock
S - Sale X -750 119,047 -0.63 20.26 -15,194 2,411,654
2022-02-03 2022-02-01 4 IMGO Imago BioSciences, Inc.
Common Stock
S - Sale X -5,750 119,797 -4.58 19.69 -113,218 2,358,815
2022-02-03 2022-02-01 4 IMGO Imago BioSciences, Inc.
Common Stock
M - Exercise X 6,500 125,547 5.46 2.10 13,650 263,649
2022-01-14 2022-01-12 4 IMGO Imago BioSciences, Inc.
Stock Option (Right to Buy)
M - Exercise X -6,000 26,738 -18.33
2022-01-14 2022-01-12 4 IMGO Imago BioSciences, Inc.
Common Stock
S - Sale X -6,000 119,047 -4.80 19.96 -119,750 2,375,976
2022-01-14 2022-01-12 4 IMGO Imago BioSciences, Inc.
Common Stock
M - Exercise X 6,000 125,047 5.04 1.52 9,120 190,071
2021-11-19 2021-11-17 4 IMGO Imago BioSciences, Inc.
Stock Option (Right to Buy)
A - Award 91,500 91,500
2021-07-15 3 IMGO Imago BioSciences, Inc.
Common Stock
119,047
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)